Open AccessAmlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
Author(s) -
Jinbiao Xiong,
Gaochao Guo,
Lianmei Guo,
Zengguang Wang,
Zhijuan Chen,
Nan Yang,
Yiyao Cao,
Ruilong Li,
Xuejun Yang,
Jun Dong,
Xun Jin,
Weidong Yang,
Qiang Huang
Publication year - 2021
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.0c05399
Subject(s) - temozolomide , pi3k/akt/mtor pathway , cancer research , protein kinase b , glioma , ampk , u87 , apoptosis , pharmacology , medicine , biology , phosphorylation , microbiology and biotechnology , protein kinase a , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom